Hernday Natasha
SEC CIK 1780547 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Dir | 15.5K | — | — | 4 | 2024-07-19 | 2026-06-11 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Janux Therapeutics, Inc. | Hernday Natasha | Dir | A - Grant | $0.00 | +5,500 | 15.5K | +55% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Janux Therapeutics, Inc. | Hernday Natasha | Dir | A - Grant | $0.00 | +3,750 | 8,731 | +75% | $0 |
| DA | 2024-07-24 | 2024-07-19 | JANX | Janux Therapeutics, Inc. | Hernday Natasha | Dir | A - Grant | $0.00 | +1,231 | 6,231 | +25% | $0 |
| DM | 2024-07-22 | 2024-07-19 | JANX | Janux Therapeutics, Inc. | Hernday Natasha | Dir | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations